Bacteriological Profile and Multidrug Resistance Patterns of Isolates from Sputum of Adults with Community Acquired Pneumonia in Diobu, Port Harcourt, Nigeria: A Retrospective Study

Chidi L.C. Ndukwu *

Faculty of Medical Laboratory Science, Federal University, Otuoke, Bayelsa State, Nigeria.

Roseanne Adah Ikpeama

Department of Medical Laboratory Science, PAMO University of Medical Sciences, Port Harcourt, Nigeria.

*Author to whom correspondence should be addressed.


Abstract

Community acquired pneumonia is a major global public health concern given its substantial contribution to the mortality and morbidity associated with infectious diseases, the huge losses in human and economic resources and the increasing challenges in treatment due to multidrug resistance (MDR). This retrospective cross sectional descriptive study reviewed laboratory records of adults clinically diagnosed with community acquired pneumonia (CAP) between January 1, 2017, and December 31, 2022. A total of 308 sputum specimens meeting the inclusion criteria were reviewed and yielded 135 (43.8%) bacterial strains. The 135 bacterial strains spread across 9 species had Streptococcus pneumoniae as the dominant species with 41(30.4%); followed by Staphylococcus aureus 21(15.6%), Escherichia coli 16(11.9%), Klebsiella pneumoniae 16(11.9%), Pseudomonas aeruginosa 12(8.9%), Streptococcus pyogenes 12(8.9%), Proteus mirabilis 10(7.4%), Enterobacter cloacae 5(3.7%) and Acinetobacter baumannii 2(1.5%). The cumulative resistance profile was 45.7%; the most resistant bacterial specie was Pseudomonas aeruginosa with a resistance profile of 50%; followed by Staphylococcus aureus (48.6%), Enterobacter cloacae (48.0%), Streptococcus pyogenes 47.5%, Streptococcus pneumoniae 47.3%, Klebsiella pneumoniae 45.6%, Proteus mirabilis 42.0%, Escherichia coli 40.0% and Acinetobacter baumannii 35.0%. The MDR prevalence was 85.9% including 36.3% extensively resistant strains; but no pan-drug resistant trains; while 14.1% were non-multidrug resistant. This study has contributed to the data on bacteriological profile and antimicrobial resistance patterns in aetiological agents of community acquired pneumonia in Port Harcourt. The high prevalence of drug resistance implies that many people are likely to be infected, while most of the antibiotics are losing potency against the bacterial pathogens. It is advised that regulatory laws on drug control be revised as it pertains antibiotics, the regulatory agencies should be compelled to perform their statutory duties while there is need to sensitize the populace on the dangers of antibiotic abuse and misuse.

Keywords: Community acquired pneumonia, public health, multidrug resistance, antimicrobial resistance, Streptococcus pneumoniae, Klebsiella pneumoniae


How to Cite

Ndukwu, Chidi L.C., and Roseanne Adah Ikpeama. 2024. “Bacteriological Profile and Multidrug Resistance Patterns of Isolates from Sputum of Adults With Community Acquired Pneumonia in Diobu, Port Harcourt, Nigeria: A Retrospective Study”. International Journal of Pathogen Research 13 (3):65-75. https://doi.org/10.9734/ijpr/2024/v13i3287.

Downloads

Download data is not yet available.

References

Lim WS. Pneumonia -Overview. Encylopedia of Respiratory Medicine Respir. Med. 2022;185-97.

Torres A, Cilloniz C, Niederman MS. Menendez R. Chalmers JD, Wunderink RG. Pneumonia. Nat Rev Dis Primers 2021;7(25). Available:https://doi.org/10.1038/s41572-021-00259-03

Mussema A, Beyene G, Gudina EK, Alelign D, Mohammed T, Bawore SG, Seid AM, Tadesse W, Gashaw M. Bacterial etiology, antimicrobial resistance and factors associated with community acquired pneumonia among adult hospitalized patients in Southwest Ethiopia. Iran J Microbiol. 2023;15(4):492-02.

Bahabri I, Abdulaal A, Alanazi T, Alenazy S, Alrumih Y, Alqahtani R, Bosaeed M, Al-Dorzi HM. Characteristics, Management, and Outcomes of Community-Acquired Pneumonia Due to Human Rhinovirus-A Retrospective Study. Can Respir J. 2022;9:1349994

Ojuawo OB, Desalu OO, Fawibe AE, Ojuawo AB, Aladesanmi AO, Opeyemi CM, Adio MO, Jimoh AO, Amadu DO, Fadeyi A, Salami KA. Clinical and microbiological profile of adult inpatients with community acquired pneumonia in Ilorin, North Central, Nigeria. Afr Health Sci. 2020;20(4):1655-68.

Ibrahim AO, Shabi OM, Aremu SK, Omosanya EO, Kolawole FT, Ajetunmobi AO. Community-acquired pneumonia and its predictors of mortality in rural southwestern Nigeria: A-five year retrospective observational study. Afr J Emerg Med. 2022;12(3):293-97.

Assefa M, Tigabu A, Belachew T, Tessema B. Bacterial profile, antimicrobial susceptibility patterns, and associated factors of community-acquired pneumonia among adult patients in Gondar, Northwest Ethiopia: A cross-sectional study. PLoS One. 2022;17(2):e0262956.

Regunath H, Oba Y. Community-Acquired Pneumonia. [Updated 2022 Nov 15]. In: Stat Pearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available:https://www.ncbi.nlm.nih.gov/books/NBK430749/

Raghubanshi BJ, Karki BS.Bacteriology of sputum samples:A descriptive Cross-sectional study in a tertiary care hospital. J. Nepal Med Assoc. 2020;58(221):24- 28.

Hassanzadeh S, Khoramrooz SS, Mazloomirad F, Sharifi A, Roustaei N, Gholamnezhad M, Jamshidnejad E. Bacterial profile and their antimicrobial resistance patterns among patients with community-acquired pneumonia in southwestern Iran. Iran J Microbiol. 2023; 15(3):343-49.

Ndukwu CLC, Akani NP. Multidrug resistance in klebsiella species isolated from liquid herbal remedies in Port Harcourt, Nigeria. IJPR. 2023;12(6):83– 91.

Ndukwu, CLC. Microbial Communities and Antimicrobial Resistance Patterns in Aerobic Bacteria Associated with the Vaginal Microbiota: A Retrospective Study in Port Harcourt, Nigeria. AJRID 2024;15(1): 39–48. Available:https://doi.org/10.9734/ajrid/2024/v15i1324.

Costin S, Ionut S. ABIS online - Advanced Bacterial Identification Software, an original tool for phenotypic bacterial identification, Regnum Prokaryotae. 2017; Available at: www.tgw1916.net.

Islam MA, Nain Z, Alam MK, Banu N A, Islam MR. In vitro study of biocontrol potential of rhizospheric Pseudomonas aeruginosa against Fusarium oxysporum f. sp. cucumerinum. EJBPC. 2018;28:90.

Ndukwu CLC, Akani NP, Wemedo SA, Sampson T.Public Health Implications Of Coliform Contaminants In Non-Packaged, Commercially Hawked Herbal Remedies Sold In Port Harcourt. JAMB. 2021;21(9):79-87

Ndukwu CLC, Akani NP, Wemedo SA, Sampson T. Bacteriological Evaluation Of Non-Regulated Herbal Remedies Sold In Port Harcourt, Nigeria. SAJRM. 2021; 10(3): 28-36.

Kowalczyk J, Czokajło I, Gańko M, Śmiałek M, Koncicki A. Identification and antimicrobial resistance in Klebsiella spp. Isolates from Turkeys in Poland between 2019 and 2022. Animals (Basel). 2022;12(22):3157.

Lupisan S, Suzuki A, Macalalad N, Egos R, Sombrero L, Okamoto M, Dapat C, Mondoy M, Galang H, Zeta VFF, de la Pena F, Romano V, Olveda R, Oshitani H. Etiology and epidemiology of community-acquired pneumonia in adults requiring hospital admission: A prospective study in rural Central Philippines. Int J Infect Dis. 2019; 80:46-53.

Tilahun M, Gebretsadik D, Seid A, Gedefie A, Belete MA, Tesfaye M, Kebede E, Shibabaw A. Bacteriology of community-acquired pneumonia, antimicrobial susceptibility pattern and associated risk factors among HIV patients, Northeast Ethiopia: cross-sectional study. SAGE Open Med. 2023;11:20503121221145569.

Ziko LM, Hoffman TW, Fwoloshi S, Chanda D, Nampungwe YM, Patel D, Bobat H, Moonga A, Chirwa L, Hachaambwa L, Mateyo KJ. Aetiology and prognosis of community-acquired pneumonia at the Adult University Teaching Hospital in Zambia. PLoS One. 2022;17(7):e0271449.

Lüthi-Corridori G, Roth AI, Boesing M, Jaun F, Tarr PE, Leuppi-Taegtmeyer AB, Leuppi JD. Diagnosis and Therapy of Community-Acquired Pneumonia in the Emergency Department: A Retrospective Observational Study and Medical Audit. J Clin Med. 2024;13(2):574.

Joelsons D, Alencar CS, Pinho JRR, Ho YL. Investigation of etiology of community-acquired pneumonia in hospitalized patients in a tertiary hospital of São Paulo City, Brazil. Braz J Infect Dis. 2023;27(6):103690.

Carugati M, Aliberti S, Sotgiu G, Blasi F, Gori A, Menendez R, et al.GLIMP Collaborators. Bacterial etiology of community-acquired pneumonia in immunocompetent hospitalized patients and appropriateness of empirical treatment recommendations: an international point-prevalence study. Eur J Clin Microbiol Infect Dis. 2020;39(8):1513-25.

Gadsby NJ, Musher DM. The Microbial Etiology of Community-Acquired Pneumonia in Adults: from Classical Bacteriology to Host Transcriptional Signatures. Clin Microbiol Rev. 2022;35(4):e0001522.

Cut TG, Mavrea A, Cumpanas AA, Novacescu D, Oancea CI, Bratosin F, Marinescu AR, Laza R, Mocanu A, Pescariu AS, Manolescu D, Dumache R, Enache A, Hogea E, Lazureanu VE. A Retrospective Assessment of Sputum Samples and Antimicrobial Resistance in COVID-19 Patients. Pathogens. 2023;12(4):620.

Regassa BT, Tosisa W, Eshetu D, Beyene D, Abdeta A, Negeri AA, Teklu DS, Tasew G, Tulu B, Awoke T. Antimicrobial resistance profiles of bacterial isolates from clinical specimens referred to Ethiopian Public Health Institute: analysis of 5-year data. BMC Infect Dis. 2023;23(1):798.

Dessie T, Jemal M, Maru M, Tiruneh M. Multiresistant Bacterial Pathogens Causing Bacterial Pneumonia and Analyses of Potential Risk Factors from Northeast Ethiopia. Int J Microbiol. 2021; 2021:6680343.

Purba AK, Ascobat P, Muchtar A, Wulandari L, Rosyid AN, Purwono PB, van der Werf TS, Friedrich AW, Postma MJ. Multidrug-Resistant Infections Among Hospitalized Adults with Community-Acquired Pneumonia in an Indonesian tertiary referral hospital. infect Drug Resist. 2019;12:3663-3675.